Josh Horhey

Bachelor of Medicine and Bachelor of Science,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Legal Support Pharma-CRO-Device Sales and Marketing

Areas Of Interest

Tucuxi Dolphin Root Canal Therapies Campomelic Dwarfisms Opioid Antagonists Movement Protein, Plant Virus CoA, Long-Chain Acyl MAP Kinase Cascade Zacin Syndrome, Acrocallosal GHS Receptor Type 1 GABA A Receptor gamma Subunit Mucinous Carcinoma Marinesco-Sjogren-Garland Syndrome gamma-Lipotrophin Services, Genetic Structures, Nonmammalian Embryonic Playings, Role Services, Hospital Laundry Nerve Block, Sympathetic Agents, Serotonergic Small-Area Study Early Proteins, Adenovirus alpha-1 Chimerin Boswellia sacra Particle, Vault Ribonucleoprotein Transcription Factor, PAX2 Adolescent Welfare Cyclic GMP Dependent Protein Kinase Type I Memory, Immunologic Allergies, Tree Nut Traumatic Vestibulocochlear Neuropathies Cystathionine beta-Synthase Weight Bearing Arterioscleroses, Coronary Determination, Endpoint

Professional Narrative

Dr. Josh Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Amgen 1989
Medical Writer, Harvard Med 2013

Education

Master of Science in physician assistant, Harvard Medical School 1993
Doctor of osteopathic medicine, Baylor College 2009

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02